EMA — authorised 15 September 2008
- Status: approved
🇪🇺 Neupogen in European Union
EMA authorised Neupogen on 15 September 2008
Marketing authorisation
Neupogen in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Neupogen approved in European Union?
Yes. EMA authorised it on 15 September 2008.
Who is the marketing authorisation holder for Neupogen in European Union?
Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.